O. Madonna

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

First Food and Drug Administration-Approved Prospective Trial of Primary Intracranial Stenting for Acute Stroke

TOR Signaling in Growth and Metabolism

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Antithrombotic Therapy for Venous Thromboembolic Disease

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Imaging microvascular obstruction and its clinical significance following acute myocardial infarction

Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock

Failure of Preventing 5-Fluorouracil Cardiotoxicity by Prophylactic Treatment with Verapamil

Management of Patients Undergoing Percutaneous Coronary Revascularization

Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: A dual‐center registry

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Acute ST-Segment Elevation Myocardial Infarction

Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Coronary artery stents: a rapid systematic review and economic evaluation

Stenting versus thrombolysis in acute myocardial infarction trial (STAT)

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention

Hypertension in the Very Elderly Trial (HYVET)

Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes

Retroinfusion‐supported stenting in high‐risk patients for percutaneous intervention and bypass surgery: Results of the prospective randomized myoprotect I study

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Primary PCI for Myocardial Infarction with ST-Segment Elevation

Myocardial ischemia-reperfusion injury: a neglected therapeutic target

Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction

Impact of Body Mass Index on Outcomes After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Percutaneous Intervention Versus Coronary Bypass Surgery for Patients Older Than 70 Years of Age With High-Risk Unstable Angina

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Minimally Invasive Hybrid Coronary Artery Revascularization

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: Results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

2007 Guidelines for the Management of Arterial Hypertension

Drug eluting stents in 2005

Coronary Artery Stents

Sex and gender: modifiers of health, disease, and medicine

Primary Coronary Intervention for Acute Myocardial Infarction

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Drug-induced heart failure

The effect of completeness of revascularization on event-free survival at one year in the arts trial

Effect of Anemia on Short- and Long-Term Outcome in Patients Hospitalized for Acute Coronary Syndromes

Fish Intake, Contaminants, and Human Health

The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale

A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction

Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures

Treatment of Hypertension in Patients 80 Years of Age or Older

Guidelines for Percutaneous Coronary Interventions

Task Force on Sudden Cardiac Death of the European Society of Cardiology

Clinical and quantitative coronary angiographic predictors of coronary restenosis

Management of acute myocardial infarction in patients presenting with ST-segment elevation

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

Myocardial Reperfusion Injury

Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction

Myocarditis

Fractional Flow Reserve for the Assessment of Nonculprit Coronary Artery Stenoses in Patients With Acute Myocardial Infarction

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction

Comparison of Percutaneous Versus Surgical Revascularization of Severe Unprotected Left Main Coronary Stenosis in Matched Patients

Outcome After Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease

On the mechanisms of biocompatibility

Reporting of Noninferiority and Equivalence Randomized Trials

Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery

Cardiac protection during acute myocardial infarction: Where do we stand in 2004?

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Losartan Potassium

Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials

Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

No-reflow phenomenon and prognosis in patients with acute myocardial infarction

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Women and Ischemic Heart Disease

Coronary-Artery Stents

Expert consensus document on arterial stiffness: methodological issues and clinical applications

A computerized intervention to decrease the use of calcium channel blockers in hypertension

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee

Chronic Kidney Disease

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

Coated Stents for the Prevention of Restenosis: Part II

Fluoropyrimidine-associated cardiotoxicity: revisited

Acute Myocardial Infarction in Women

Claims of Equivalence in Medical Research: Are They Supported by the Evidence?

Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes

Acute Renal Failure Definitions and Classification

International Union of Pharmacology. XXIII. The Angiotensin II Receptors

Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Clinical End Points in Coronary Stent Trials

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery

Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction

Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Volume-Outcome Relation for Physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction

Myocardiotoxicity of 5 Fluorouracil

Lisinopril versus atenolol: Decrease in systolic versus diastolic blood pressure with converting enzyme inhibition

A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice

Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension

Coronary Angioplasty With or Without Stent Implantation for Acute Myocardial Infarction

The ARTS study (Arterial Revascularization Therapies Study).